Keystone EC - Search Results

1

A Bridge Too Far? Real-World Practice Patterns of Early Glucocorticoid Use in the Canadian Early Arthritis Cohort.

Andersen KM, Schieir O, Valois MF, Bartlett SJ, Bessette L, Boire G, Haraoui B, Hazlewood G, Hitchon C, Keystone EC, Pope J, Tin D, Throne JC, Bykerk VP; CATCH Investigators. Andersen KM, et al. Among authors: keystone ec. ACR Open Rheumatol. 2022 Jan;4(1):57-64. doi: 10.1002/acr2.11334. Epub 2021 Oct 28. ACR Open Rheumatol. 2022. PMID: 34708574 Free PMC article.

2

Serial levels of soluble interleukin 2 receptor in the peripheral blood of patients with rheumatoid arthritis: correlations with disease activity.

Rubin LA, Snow KM, Kurman CC, Nelson DL, Keystone EC. Rubin LA, et al. Among authors: keystone ec. J Rheumatol. 1990 May;17(5):597-602. J Rheumatol. 1990. PMID: 2359067

3

Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis.

Keystone EC, Snow KM, Bombardier C, Chang CH, Nelson DL, Rubin LA. Keystone EC, et al. Arthritis Rheum. 1988 Jul;31(7):844-9. doi: 10.1002/art.1780310704. Arthritis Rheum. 1988. PMID: 3134896

4

Is there a relationship between autoantibodies and silicone-gel implants?

Peters W, Keystone E, Snow K, Rubin L, Smith D. Peters W, et al. Ann Plast Surg. 1994 Jan;32(1):1-5; discussion 5-7. doi: 10.1097/00000637-199401000-00001. Ann Plast Surg. 1994. PMID: 8141526

5

Systemic vasculitis following influenza vaccination--report of 3 cases and literature review.

Mader R, Narendran A, Lewtas J, Bykerk V, Goodman RC, Dickson JR, Keystone EC. Mader R, et al. Among authors: keystone ec. J Rheumatol. 1993 Aug;20(8):1429-31. J Rheumatol. 1993. PMID: 8230034 Review.

6

Thalidomide in the treatment of refractory rheumatoid arthritis.

Keesal N, Wasserman MJ, Bookman A, Lapp V, Weber DA, Keystone EC. Keesal N, et al. Among authors: keystone ec. J Rheumatol. 1999 Nov;26(11):2344-7. J Rheumatol. 1999. PMID: 10555888 Clinical Trial.

7

Biologic agents in the treatment of rheumatoid arthritis.

Haraoui B, Strand V, Keystone E. Haraoui B, et al. Curr Pharm Biotechnol. 2000 Nov;1(3):217-33. doi: 10.2174/1389201003378915. Curr Pharm Biotechnol. 2000. PMID: 11469381 Review.

8

Current and emerging therapies for rheumatoid arthritis, with a focus on infliximab: clinical impact on joint damage and cost of care in canada.

Russell A, Haraoui B, Keystone E, Klinkhoff A. Russell A, et al. Clin Ther. 2001 Nov;23(11):1824-38; discussion 1791. doi: 10.1016/s0149-2918(00)80079-x. Clin Ther. 2001. PMID: 11768835 Review.

9

Role of adalimumab in the treatment of early rheumatoid arthritis.

Keystone EC, Haraoui B, Bykerk VP. Keystone EC, et al. Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S198-9. Clin Exp Rheumatol. 2003. PMID: 14969077 Clinical Trial.

10

Role of infliximab in the treatment of early rheumatoid arthritis.

Keystone EC, Haraoui B, Bykerk VP. Keystone EC, et al. Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S200-2. Clin Exp Rheumatol. 2003. PMID: 14969078 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

343 results

Search Page